HLA-B27 subtypes and tumor necrosis factor α promoter region polymorphism in Iranian patients with ankylosing spondylitis

European Cytokine Network

Volumn 20, Issue 1, 2009, Pages 17-20

  Nicknam, Mohammad Hossein ^a   Mahmoudi, Mahdi ^a   Amirzargar, Ali Akbar ^a   Jamshidi, Ahmad Reza ^b   Rezaei, Nima ^c   Nikbin, Behrouz ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ankylosing spondylitis; HLA B27; MHC class I; Polymorphism; TNF

Indexed keywords

HLA B27 ANTIGEN; HLA B2702 ANTIGEN; HLA B2705 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; CHILD; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENOTYPE; HLA TYPING; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN DETERMINATION; SCHOOL CHILD; SCREENING;

ADOLESCENT; ADULT; ALLELES; CASE-CONTROL STUDIES; CHILD; FEMALE; GENE FREQUENCY; GENOTYPE; HLA-B27 ANTIGEN; HUMANS; IRAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 66249084824     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2009.0143     Document Type: Article

References (30)

1. Cipriani A, Rivera S, Hassanhi M, et al. HLA-B27 subtypes determination in patients with ankylosing spondylitis from Zulia, Venezuela. Hum Immunol 2003: 745-749 (Pubitemid 36828506)
2. Oguz F, Ocal L, Diler A, et al. HLA- B27 in Turkish patients with spondyloarthropathy and healthy controls. Disease Markers 2004; 20: 309-312 (Pubitemid 40385310)
3. Gonzalez S, Garcia-Fernandez S, Martinez-Borra J, Blanco-Gelaz M, Rodrigo L, Sanchez del Rio J. High variability of HLA-B27 alleles in ankylosing spondylitis and related spondyloarthropathies in the population of northern Spain. Hum Immunol 2002: 673-676
4. Varnavidou-Nicolaidou A, Karpasitou K, Georgiou D, Stylianou G, Kokkofitou A, Michalis C. HLA-B27 in the Greek Cypriot population: distribution of subtypes in patients with ankylosing spondylitis and other HLA-B27-related diseases. The possible protective role of B*2707. Hum Immunol 2004; 65: 1451-1454
5. Brinkman B, Huizinga T, Kurban S, et al. Tumour necrosis factor a gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheum 1997; 36: 516-521 (Pubitemid 27344484)
6. Nicknam MH, Mahmoudi M, Amirzargar AA, et al. Determination of HLA-B27 subtypes in Iranian patients with ankylosing spondylitis. Iran J Allergy Asthma Immunol 2008; 7: 19-24.
7. Shankarkumar U, Ghosh K, Mohanty D. HLA B27 polymorphism in Western India. Tissue Antigens 2002; 60: 98-101. (Pubitemid 35177032)
8. Khan M. Update: the twenty subtypes of HLA-B27. Curr Opin Rheumatol 2000; 12: 235-238 (Pubitemid 30439673)
9. Kaijzel E, Brinkman B, van Krugten M, et al. Polymorphism within the Tumor Necrosis Factor alpha promoter region in patients with ankylosing spondylitis. Human Immunol 1999; 60: 140-144 (Pubitemid 29072097)
10. Sklatvala J. Tumor necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986; 322: 547-549 (Pubitemid 16049204)
11. Verjans GM, Brinkman BM, Van Doornik CE, Kijlstra A, Verweij CL. Polymorphism of tumour necrosis factor-alpha (TNF-a) at position -308 in relation to ankylosing spondylitis. Clin Exp Immunol 1994; 97: 45-47 (Pubitemid 24244053)
12. Verjans GM, Messer G, Weiss EH, van der Linden SM, Kijlstra A. Polymorphism of the tumor necrosis factor region in relation to disease: an overview. Rheumat Dis Clin North Am 1992; 18: 177-186
13. Campbell D, Trowsdale J. Map of the human histocompatibility complex. Immunol Today 1993: 14.
14. Jacob C, Fronek Z, Lewis G, Koo M, Hansen J, McDevitt H. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor a: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad of Sci USA 1990; 87: 1233-1237 (Pubitemid 20057200)
15. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS. Genetic variability in the TNF-a promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Com 1995; 211: 833-839
16. D'Alfonso S, Momigliano Richiardi P. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994; 39: 150-154 (Pubitemid 23344817)
17. Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007; 369: 1379-1390 (Pubitemid 46590387)
18. Nicknam M, Jamshidi A. M GH. Comparison of validity of microlymphocytotoxicity and flowcytometry methods with PCR for HLA-B27 antigen typing. Med JIR Iran 2003; 17: 75-79 (Pubitemid 37435010)
19. Voorter C, Swelsen W, van den Berg-Loonen E. B*27 in molecular diagnostics: impact of new alleles and polymorphism outside exons 2 and 3. Tissue Antigens 2002; 60: 25-35. (Pubitemid 35177021)
20. Nicknam M, Ganjalikhani Hakemi M, Jamshidi A. Association between HLA-B27 antigen and ankylosing spondylitis in Iranian patients. Hakim Journal 2005; 8: 29-34.
21. Fraile A, Nieto A, Beraun Y, Vinasco J, Mataran L, Martin J. Tumor necrosis factor gene polymorphisms in ankylosing spondylitis. Tissue Antigens 1998; 51: 386-390 (Pubitemid 28154488)
22. McGuire W, Hill A, Allsopp C, Greenwood B, Kwiatkowski D. Variation in the TNF-a promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-510 (Pubitemid 2138419)
23. Hoffmann SC, Stanley EM, Darrin Cox E, et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28 stimulated peripheral blood lymphocytes. Transplantation 2001; 72: 1444-1450 (Pubitemid 33015773)
24. Erbek SS, Yurtcu E, Erbek S, Atac FB, Sahin FI, Cakmak O. Proinflammatory cytokine single nucleotide polymorphisms in nasal polyposis. Arch Otolaryngol Head Neck Surg 2007; 133: 705-709 (Pubitemid 47080424)
25. Huizinga T, Westendorp R, Bollen E, et al. TNF-a polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 1997; 72: 149-153 (Pubitemid 27062770)
26. Rezaei N, Amirzargar AA, Shakiba Y, Mahmoudi M, Moradi B, Aghamohammadi A. Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency. Clin Exp Immunol 2009; 155: 21-27
27. Mahdaviani SA, Rezaei N, Moradi B, Dorkhosh S, Amirzargar AA, Movahedi M. Proinflammatory cytokine gene polymorphisms among Iranian patients with asthma. J Clin Immunol 2009: 28.
28. Amirzargar AA, Bagheri M, Ghavamzadeh A, et al. Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia. Int J Immunogenet 2005; 32: 167-171 (Pubitemid 40768933)
29. Amirzargar AA, Rezaei N, Jabbari H, et al. Cytokine single nucleotide polymorphisms in Iranian patients with pulmonary tuberculosis. Eur Cytokine Netw 2006; 17: 84-89
30. Vinasco J, Beraun Y, Nieto A, et al. Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens 1997; 49: 74-78 (Pubitemid 27039258)